Sympathetic neurotransmitters are diminished in cardiac sympathetic efferent nerve endings in congestive heart failure (CHF). Similar changes occur after exogenous NE infusion.
INTRODUCTION
We have shown previously that the cardiac sympathetic efferent postganglionic nerve terminal function is abnormal in chronic heart failure (CHF), as evidenced by the decrease of norepinephrine (NE) uptake activity, NE uptake-1 site density, neuronal catecholaminergic histofluorescence profiles, tyrosine hydroxylase immunostained profiles, and neuropeptide Y immunostained profiles (14, 16, 31) . This is believed to be a response to increased cardiac interstitial NE concentration, because similar changes occur after NE infusion in animals (14, 20) . Furthermore, since the effects of NE were prevented by antioxidant vitamins or free radical scavengers (20) , the changes on sympathetic nerve endings are thought to be caused by formation of NE-derived oxygen free radicals. However, the exact mechanism by which NE causes the changes is not known. Recently, NE has been shown to reduce the protein and mRNA expression of nerve growth factor (NGF) in cultured neonatal rat myocytes, suggesting a potential linkage of NE and NGF to the cardiac sympathetic nerve terminal dysfunction in heart failure (17) .
NGF protein and mRNA are produced in target tissues of the peripheral sympathetic and sensory nervous system and PC12 cells (15, 18, 29) . NGF plays an important role in neuronal differentiation, maturation and survival (15, 19) . These effects of NGF are mediated largely via the high-affinity neurotrophic receptor tyrosine kinase (TrKA) (13) .
The purpose of this study was to determine whether the changes in cardiac sympathetic nerve terminal function produced by NE infusion or in CHF were associated with a reduction of myocardial NGF or TrKA. We measured the protein and mRNA expressions of NGF and TrKA, using Western blot analysis and reverse transcription polymerase chain reaction (RT-PCR), respectively. Tissue distributions of the NGF or TrKA in the heart were determined using immunocytochemistry. Finally, we measured the profiles of neuronal catecholaminerigic histofluorescence and tyrosine hydroxylase in the heart. Results of the our study indicate that the cardiac NGF and TrKA levels correlated with the density of sympathetic nerve transmitters.
METHODS

Animal preparation
The present study was approved by the University of Rochester Committee Animal Resources and conformed to the guiding principles approved by the Council of American Physiological Society and the National Institutes of Health Guide on the humane care and use of laboratory animals. Two different experimental protocols were used in this study.
1.
Chronic heart failure Adult mongrel dogs weighing 20.3 to 25.6 kg were anesthetized with intravenous sodium pentobarbital (25 mg/kg), and artificially ventilated using a Harvard ventilator. A sterile left thoracotomy was then performed for insertion of heparin-filled Tygon catheters into the main pulmonary artery, left atrium, and thoracic aorta and a Konigsberg micromanometer (Konigsberg Instrument, Pasadena, CA) into the left ventricle through a stab wound in the apex (14) . A Medtronic pulse generator (Medtronic, Minneapolis, MN) which had been modified for rapid pacing was implanted in a cervical pocket and connected to a bipolar transvenous ventricular pacing lead positioned in the apex of the right ventricle through an external jugular vein. The chest was then closed.
Animals were assigned, one week after thoracotomy, to receive either rapid ventricular 
Resting hemodynamic measurements
Animals were acclimatized to the laboratory and trained to lie quietly on a 
Plasma NE concentration
Arterial blood was collected into ice-cold tubes containing reduced glutathione. The blood was centrifuged, and the plasma was stored at -70 °C for subsequent radioenzymatic NE assay (26), using Cat-A-Kit assay system (Amersham Corp., Arlington Heights, IL).
Animal sacrifice and tissue preparation
After hemodynamic studies, the animal was given a lethal dose (>100 mg/kg) of sodium pentobarbital. The heart was removed and weighed. The left ventricular free wall was either quickly frozen in liquid nitrogen and stored for subsequent studies or processed immediately for measuring 1) myocardial NGF and NGF receptor TrKA proteins using Western blot analysis and immunocytochemistry, 2) cardiac total RNA isolation and NGF and TrKA mRNAs using RT-PCR, and 3) cardiac sympathetic nerve terminal profiles of NE by histofluorescence and tyrosine hydroxylase by immunocytochemistry.
Western blot analysis for NGF and its receptor TrKA proteins
Left ventricular tissue was homogenized in a lysis buffer containing 100 mM Tris-HCl 
Immunocytochemistry for the location of NGF and its receptor TrKA expression
To determine localization of NGF within the myocardium, myocardial muscle samples were fixed in 10% neutral buffered formalin, embedded with paraffin and then sectioned. The 
RNA isolation and RT-PCR for NGF mRNA expression
Total RNA was isolated from left ventricular tissue using Trisolv reagents (Life Technologies, Grand Island, NY), as we described previously (27) . RT-PCR was used to measure NGF and TrKA mRNAs, using an Enhanced Avian RT-PCR kit (Sigma Chemical Co.).
According to the published sequences (37, 38) , primers were synthesized for NGF (sense, 5'-TCATCCACCCACCCAGTC-3' and anti-sense, 5'-ACACGCAGGCTGTATCTA-3'), TrKA °C denaturing for 30 sec, 58 °C annealing for 1 min and 72 °C extension for 2 min. The PCR products were resolved on a 5% polyacrylamide native gel with a buffer containing 45 mM Trisborate and 1 mM EDTA. The gels were dried, and exposed to Kodak X-OMAT film at -70 °C and autoradiographs quantified using a GS-700 imaging densitometer. The optical densities of the NGF and TrKA bands were subsequently normalized to that of the housekeeping gene GAPDH. The optical density readings were expressed as ratios to a reference sample taken from a control pacing or saline infused dog, which was assigned an arbitray value of 1. The tissue block preparation for noradrenergic nerve terminal transmitter profiles was described previously (14) . Catecholaminergic histofluorescence was measured using the sucrosepotassium phosphate-glyoxylic acid (SPG) condensation method (3) 
Noradrenergic nerve terminal transmitter profiles
Statistical analysis
Results are presented as means±SE. Student's t-test for unpaired data was used to determine the statistical significance of differences between the CHF and control groups, as well as differences between the NE-and saline-infusion groups. A difference with p<0.05 was considered significant. The Pearson product-moment correlation coefficient analysis was used to determine the relationship between the number of sympathetic nerve transmitter profiles and NGF or TrKA protein contents. Table 1 shows that the CHF dogs exhibited elevated heart rate, left atrial pressure and left ventricular end-diastolic pressure, and lower mean aortic pressure, left ventricular peak dP/dt and cardiac output compared to the control animals. CHF animals also showed a 5-fold increase in plasma NE compared to the control animals.
RESULTS
Resting hemodynamics, plasma NE and heart weight
NE infusion caused a marked increase in plasma NE and a slight reduction of heart rate.
However, there were no significant changes in mean aorta pressure, left atrial pressure, left ventricular end-diastolic pressure, left ventricular peak dP/dt and cardiac output between the NEand saline infusion groups. Table 1 also shows that left ventricular weight increased slightly in CHF dogs compared to the control animals without CHF. Left ventricular weight was higher in dogs with NE infusion, but the difference in left ventricular weight between NE and saline infusion groups did not reach statistical significance.
Myocardial NGF and TrKA protein expression by Western blot and immunocytochemistry
Representative Western blots for myocardial NGF and TrKA proteins are shown on Figures 1 and 2 . PC12 cells were used as a source for positive control for TrKA ( Figure 2 ). The group data on Figure 3 show that the myocardial contents of NGF and TrKA were reduced in both CHF and NE-infused dogs compared to the control and saline-infused animals.
The primary antibody chosen for the study was specific for NGF. No protein expression was seen when normal rabbit IgG was used in place of the primary antibody in the reaction ( Figure 4) . The protein expression also was not seen when the blocking peptide for NGF was used along with the primary antibody (data not shown). To determine the cellular localization of NGF, we carried out the immune fluorescence staining in a control dog heart muscle with double labeling for myosin β-heavy chain and NGF. Figure 4 shows that NGF and myosin β-heavy chain were co-localized in the same cells, indicating that NGF was expressed in the cytoplasma of cardiomyocytes.
In addition, using immunocytochemical analysis ( Figure 5 ), we showed that NGF protein expression was markedly decreased in CHF or NE-treated animals compared to the control pacing or saline infusion dog. However, unlike NGF which is present in cardiomyocytes, TrKA expression was abundant only around intramyocardial blood vessels ( Figure 6 ). Little TrKA immunoreactivity was noted within cardiomyocytes. It is evident from both the Western blots and immunocytochemical staining that NGF and TrKA protein was both reduced in the CHF and NE treated animals, as compared to the control and saline-treated animals. Figure 7 shows that representative gel electrophoresis of the RT-PCR products of NGF and TrKA mRNAs. The NGF and TrKA mRNA levels were normalized to that of GAPDH. Figure 8 shows that NGF and TrKA mRNA levels were both reduced in the CHF and NE-treated animals, when compared to their respective control groups. Figure 9 shows that the cardiac noradrenergic terminal transmitter (catecholaminergic and tyrosine hydroxylase) profiles were reduced in both CHF and NE infused animals. We also plotted the noradrenergic terminal transmitter profiles against the tissue NGF ( Figure 10 ) and
NGF and TrKA mRNA expression by RT-PCR
Catecholaminergic histofluorescence and tyrosine hydroxylase immunostained nerve profiles
TrKA protein ( Figure 11 ). The coefficients of correlation (r) were statistically significant. The quantities r 2 indicate that 60-77% of the variances of catecholaminergic and tyrosine hydroxylase profiles are associated with linear regressions on NGF or TrKA content.
DISCUSSION
Our present study is the first one to indicate close correlations between NGF or TrKA levels with cardiac sympathetic nerve terminal transmitter profiles in intact animals with CHF and NE infusion. Although a direct causal relationship has not been established, the data (r 2 ) support that NGF and TrKA levels may account for 60-77% of the changes in cardiac sympathetic neurotransmitter profiles. Furthermore, since both experimental models have been shown to cause an elevation in cardiac interstitial NE (4), results of our present study suggest that elevated NE may play a role in the reduction of cardiac NGF and TrKA, and thus contributes to the abnormalities in cardiac sympathetic nerve terminal function in CHF. Tissue interstitial NE content may be increased by either an increased release of NE, a decreased clearance of NE or both. It is speculated that the cardiac interstitial NE is increased in early CHF because of heightened cardiac sympathetic activity resulting in increased NE release from the sympathetic postganglionic nerve endings, but as the number of functioning sympathetic nerve terminals decreases in advanced heart failure, decreased NE uptake may play an increasingly important role for the increased cardiac interstitial NE concentration.
Involvement of NGF reduction in sympathetic nerve terminal dysfunction
NGF is the first discovered and best known member of the neurotrophic factor family (34) . Its mature active form is a dimer of two 118 amino-acid polypeptides. NGF is produced in target tissues of the peripheral sympathetic and sensory nervous systems, and binds to the TrKA (p140) receptor to elicit a cascade of intracellular events involved in neuronal differentiation, maturation and survival (13, 18, 35) . The expression of NGF correlates with the density of sympathetic innervation in effector organs, including the heart (30) , and the amount of NGF can affect the sympathetic nerve survival and synaptic transmission between neurons and cardiac myocytes (21, 22) . Our present study showed that the cardiomyocyte was a potential cellular source, as evidenced by NGF expression in cardiomyocytes of myocardial tissue. Our study also showed that NGF protein and mRNA were decreased in pacing-induced dog heart failure, and that the reduction of cardiac NGF production was associated with a decrease of sympathetic neurotransmitter profiles in CHF. Likewise, NGF levels and catecholaminergic fluorescence were reduced in the failing rat heart following coronary artery occlusion (17) . In addition, a marked reduction of cardiac release of NGF (difference between coronary sinus and artery plasma NGF) has been reported in heart failure patients (17) . Other studies have demonstrated that decreased availability of NGF is responsible for the pathogenesis of diabetic polyneuropathy (12, 24) . Heterogeneous cardiac sympathetic denervation in streptozotocin-induced diabetes also has been shown to be associated with regional depletion of myocardial NGF protein (28) . These findings indicate a potential correlation exists between NGF reduction and sympathetic nerve abnormalities in a variety of cardiovascular disease.
Like NGF, TrKA may modulate the growth of the sympathetic nerves; deletion of TrKA gene in mice has resulted in extensive neuronal cell loss in sympathetic ganglia (32) . Activated
TrK receptors have been shown to function as rapid retrograde signal carriers in response to target-derived neurotrophins (1) . In our present study, tissue TrKA protein and mRNA decreased in CHF and NE-infused dog, a finding also reported in rats with ischemic cardiomyopathy (17) . Our immunocytochemistry also revealed that TrKA was expressed predominantly in the perivascular region, presumably in the neuronal plexus. This is consistent with the prior findings that TrKA is localized on sensory and sympathetic neurons and PC12 cells.
Effects of NE on NGF production
Arterial circulating and cardiac interstitial NE concentrations are increased in CHF (4, 36) . Evidence has accumulated that NE regulates NGF synthesis and secretion in sympathetic target organs (5, 6, 33) . However, the effects of NE on NGF production vary from tissue to tissue (25) . β-Adrenergic receptor agonist stimulation has been shown to increase NGF production in neuronal cells (7, 8) , and vascular smooth muscle cells (2) . In contrast, NE decreased NGF and mRNA levels in dose-dependent manner in the iris (11) and brown adipose tissue (23) . Our present study has extended the prior observations in cultured cardiac cells (17) to intact animals that NE infusion decreases myocardial NGF. The findings suggest that NE-induced NGF reduction contributes to cardiac sympathetic nerve terminal dysfunction in CHF.
Possible mechanisms of NE-mediated NGF reduction
Kaye et al. (17) reported that the NE-induced reduction of NGF in cultured myocytes was abolished by the α-adrenergic receptor antagonist prazosin, while propranolol, a β-adrenergic receptor blocker, had no effect. The findings indicate that this effect of NE on NGF is mediated by an α-adrenergic receptor-coupled protein kinase C signal pathway. However, conflicting data exist. Hellweg et al. (11) showed the effect of NE on cultured rat iris NGF was not abolished by phentolamine, an α-adrenergic receptor blocker. In addition, studies have shown that NGF mRNA expression is reduced by oxidative stress, and that the reduction of NGF is abolished by antioxidants (9) . However, whether the effect of NE on cardiac NGF reduction is related to the increased production of oxygen free radicals remains to be investigated.
Conclusions
Our present findings indicate that the heightened sympathetic state of CHF is associated 
